NEUROCRINE BIOSCIENCES INC Quarterly Debt-to-equity in % from Q1 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Neurocrine Biosciences Inc quarterly Debt-to-equity history and growth rate from Q1 2012 to Q3 2024.
  • Neurocrine Biosciences Inc Debt-to-equity for the quarter ending September 30, 2024 was 37.8 %, a 7% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 37.8 -2.84 -7% Sep 30, 2024
Q2 2024 41.1 +1.36 +3.43% Jun 30, 2024
Q1 2024 43.8 +4.23 +10.7% Mar 31, 2024
Q4 2023 42.5 -0.31 -0.73% Dec 31, 2023
Q3 2023 40.6 -5.33 -11.6% Sep 30, 2023
Q2 2023 39.7 -9.19 -18.8% Jun 30, 2023
Q1 2023 39.6 -12.4 -23.8% Mar 31, 2023
Q4 2022 42.8 -8.86 -17.2% Dec 31, 2022
Q3 2022 45.9 -6.48 -12.4% Sep 30, 2022
Q2 2022 48.9 -10.6 -17.8% Jun 30, 2022
Q1 2022 52 -14.4 -21.7% Mar 31, 2022
Q4 2021 51.6 -25 -32.6% Dec 31, 2021
Q3 2021 52.4 -38.9 -42.6% Sep 30, 2021
Q2 2021 59.5 -36.1 -37.8% Jun 30, 2021
Q1 2021 66.3 -38.8 -36.9% Mar 31, 2021
Q4 2020 76.6 -37.7 -33% Dec 31, 2020
Q3 2020 91.3 -24.2 -20.9% Sep 30, 2020
Q2 2020 95.5 -21.4 -18.3% Jun 30, 2020
Q1 2020 105 -12.1 -10.3% Mar 31, 2020
Q4 2019 114 +0.32 +0.28% Dec 31, 2019
Q3 2019 115 -2.21 -1.88% Sep 30, 2019
Q2 2019 117 -4.56 -3.75% Jun 30, 2019
Q1 2019 117 -3.16 -2.62% Mar 31, 2019
Q4 2018 114 +13.3 +13.2% Dec 31, 2018
Q3 2018 118 +43.8 +59.4% Sep 30, 2018
Q2 2018 122 +77.9 +179% Jun 30, 2018
Q1 2018 120 +106 +726% Mar 31, 2018
Q4 2017 101 +87.5 +663% Dec 31, 2017
Q3 2017 73.8 +61.5 +501% Sep 30, 2017
Q2 2017 43.6 +32.1 +280% Jun 30, 2017
Q1 2017 14.6 +3.93 +36.9% Mar 31, 2017
Q4 2016 13.2 +3.16 +31.5% Dec 31, 2016
Q3 2016 12.3 +1.89 +18.2% Sep 30, 2016
Q2 2016 11.5 +0.25 +2.23% Jun 30, 2016
Q1 2016 10.7 -1.81 -14.5% Mar 31, 2016
Q4 2015 10.1 -4.46 -30.7% Dec 31, 2015
Q3 2015 10.4 -5.65 -35.2% Sep 30, 2015
Q2 2015 11.2 -7.3 -39.4% Jun 30, 2015
Q1 2015 12.5 -9.98 -44.5% Mar 31, 2015
Q4 2014 14.5 -13.5 -48.2% Dec 31, 2014
Q3 2014 16.1 -11.6 -41.9% Sep 30, 2014
Q2 2014 18.5 -10.7 -36.7% Jun 30, 2014
Q1 2014 22.4 -9.55 -29.9% Mar 31, 2014
Q4 2013 28 -8.69 -23.7% Dec 31, 2013
Q3 2013 27.6 -23.6 -46% Sep 30, 2013
Q2 2013 29.3 -42.9 -59.4% Jun 30, 2013
Q1 2013 32 -85.6 -72.8% Mar 31, 2013
Q4 2012 36.7 Dec 31, 2012
Q3 2012 51.2 Sep 30, 2012
Q2 2012 72.2 Jun 30, 2012
Q1 2012 118 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.